Maple Grove-based Upsher-Smith Laboratories has agreed to sell its generic pharmaceuticals business for $1.05 billion to Sawai Pharmaceutical Co. of Japan. English-born pharmacist and chemist ...

Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48 generic products with manufacturing facilities in Plymouth and Maple Grove, Minn.

MAPLE GROVE, Minn., April 4, 2025 /PRNewswire/ — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its participation at the 2025 American Academy of Neurology (AAN) Annual Meeting ...

MAPLE GROVE, Minn., June 26, 2023 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has entered into a definitive agreement under which New Jersey-based Tonix ...

Upsher-Smith Laboratories said Wednesday that it plans to acquire Proximagen Group, a London-based pharmaceutical company developing novel drug therapies related to central nervous system diseases ...

Pharmaceutical company Upsher-Smith Laboratories Inc. will shutter its Plymouth office and locally lay off 58 employees.

Upsher-Smith was recently named by The Association of Strategic Alliance Professionals as an ASAP Alliance Excellence Award winner. ASAP recognized Upsher-Smith’s achievements in the Alliance ...

MAPLE GROVE, Minn., Dec. 2, 2024 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its participation at AES 2024, the Annual Meeting of the American Epilepsy Society ...

About Upsher-Smith Upsher-Smith Laboratories, LLC, now a member of Bora Group, is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an ...

Upsher-Smith's rare disease portfolio continues to grow with the addition of high-quality medications that match or exceed the level of service provided by innovator brands. The Company offers ...